The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously performing cancer diagnosis, treatment, and immune response induction. Compared to conventional nanomaterials that only perform one function, this new material significantly enhances treatment efficiency and is expected to serve as a next-generation cancer therapy platform utilizing nanotechnology.
